It’s no secret that America is facing an obesity crisis. But is there hope on the horizon? The new wave of weight-loss medications — Wegovy and Zepbound  — certainly seem to be game changers. Whereas previous options helped people lose only around 5% of their weight, these new medications can lead to up to 22% weight loss. But you’re not alone if you have questions. In this episode, we discuss everything we know (and don’t yet know) about the new class of weight-loss medications.Expert: Dr. Garth Davis, Weight Loss SurgeonInterviewer: Zach MooreNotable topics covered: How weight-loss medication compares to bariatric surgeryWeight-loss medications vs. supplementsThe many reasons why losing weight often isn’t as simple as diet and exercise How the new wave of weight-loss medications workAll about GLP-1 agonists, including why achieving “the GLP-1 effect” promotes weight lossWho should consider taking these medications? And are they covered by insurance? Just one tool to get weight off: why diet and exercise still matterWill you need to stay on this medication forever?How these medications also benefit heart health, type 2 diabetes management and moreThe potential side effects of weight-loss medicationsIf you enjoy these kinds of conversations, be sure to subscribe. And for more topics like this, visit our blog at houstonmethodist.org/blog.

Ver todos los episodios